Related Experiment Video
Updated: Jun 4, 2026

Quantitative Determination of De Novo Fatty Acid Synthesis in Brown Adipose Tissue Using Deuterium Oxide
Published on: May 12, 2023
Reductive death is averted by a conserved de novo lipogenic switch
Fasih M Ahsan1, Jen F Rotti2, Armen I Yerevanian3
1Department of Medicine, Diabetes Unit and Center for Genomic Medicine, Massachusetts General Hospital, Boston, MA 02114, USA; Program in Biological and Biomedical Sciences, Division of Medical Sciences, Harvard Medical School, Boston, MA 02115, USA.
Biguanides like metformin can cause toxicity by accumulating damaging reducing equivalents. This unexpected side effect requires de novo lipogenesis for defense, impacting health span and lifespan outcomes.
Area of Science:
- Biochemistry
- Gerontology
- Metabolic diseases
Background:
- Biguanides, such as metformin, are widely used oral hypoglycemic agents known to extend health span and lifespan.
- Metformin's safety is generally assumed, with toxicity only expected at very high doses.
Purpose of the Study:
- To investigate the unanticipated toxicity of biguanides.
- To identify the defense mechanisms against biguanide-induced toxicity.
- To explore the role of lipogenesis in mitigating these effects.
Main Methods:
- Investigated biguanide effects on reducing equivalents (NADPH, NADH, GSH) in various organisms.
- Assessed the role of de novo lipogenesis and fatty acid biosynthesis in response to biguanide treatment.
- Examined interventions that generate NADPH under conditions of impaired lipogenesis.
Main Results:
- Biguanide treatment leads to the accumulation of damaging reducing equivalents, specifically NADPH toxicity.
- Impaired de novo lipogenesis exacerbates NADPH toxicity, causing elevated NADH/GSH and accelerated death.
- De novo lipogenesis is crucial for preventing shortened survival during NADPH-generating interventions.
Conclusions:
- Biguanide toxicity arises from the accumulation of damaging reducing equivalents, challenging the assumption of their universal safety.
- De novo lipogenesis acts as a critical defense mechanism against biguanide-induced reductive stress.
- Fatty acid biosynthesis represents a potential therapeutic target for managing biguanide side effects and treating reductive stress-sensitive cancers.
Related Concept Videos
Lipid Catabolism
Necrosis
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become anucleated and die, but their...
Overview of Lipid Metabolism
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Tissue Renewal without Stem Cells
However, failure of such a system...
Overview of Cell Death
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the 20th century...
Biosynthesis of Lipids
